V

Vaxart
D

VXRT

0.70980
USD
0.01
(0.95%)
مغلق
حجم التداول
85,697
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
161,465,170
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    APDN
    -0.00530
    (-3.25%)
    0.15790 USD
    AZN
    AZN
    -0.350
    (-0.47%)
    74.220 USD
    BNTX
    BNTX
    2.240
    (1.90%)
    120.100 USD
    C
    CODX
    0.01720
    (2.46%)
    0.71700 USD
    I
    INO
    0.02000
    (0.91%)
    2.23000 USD
    MRNA
    MRNA
    1.785
    (5.29%)
    35.535 USD
    N
    NVAX
    0.05500
    (0.69%)
    7.98000 USD
    PFE
    PFE
    0.405
    (1.56%)
    26.305 USD
    REGN
    REGN
    4.37
    (0.63%)
    700.66 USD
    V
    VIR
    -0.22000
    (-2.24%)
    9.58000 USD
    VRTX
    VRTX
    4.10
    (0.85%)
    484.53 USD
    المزيد
الأخبار
المقالات

العنوان: Vaxart

القطاع: Healthcare
الصناعة: Biotechnology
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.